164 related articles for article (PubMed ID: 16772722)
1. Differential effects of salbutamol and montelukast on eosinophil adhesion and superoxide anion generation.
Kushiya M; Saito K; Kikuchi I; Kobayashi T; Hagiwara K; Kanazawa M; Nagata M
Int Arch Allergy Immunol; 2006; 140 Suppl 1():17-22. PubMed ID: 16772722
[TBL] [Abstract][Full Text] [Related]
2. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation.
Noguchi T; Nakagome K; Kobayashi T; Ueda Y; Soma T; Nakamoto H; Nagata M
Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080
[TBL] [Abstract][Full Text] [Related]
3. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
Langlois A; Ferland C; Tremblay GM; Laviolette M
J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil superoxide anion generation induced by adhesion molecules and leukotriene D4.
Mori M; Takaku Y; Kobayashi T; Hagiwara K; Kanazawa M; Nagata M
Int Arch Allergy Immunol; 2009; 149 Suppl 1():31-8. PubMed ID: 19494502
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene D4 and eosinophil transendothelial migration, superoxide generation, and degranulation via beta2 integrin.
Saito K; Nagata M; Kikuchi I; Sakamoto Y
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):594-600. PubMed ID: 15609771
[TBL] [Abstract][Full Text] [Related]
6. Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.
Meliton AY; Munoz NM; Leff AR
J Allergy Clin Immunol; 2007 Dec; 120(6):1316-23. PubMed ID: 17904626
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.
Tachibana A; Kato M; Kimura H; Fujiu T; Suzuki M; Morikawa A
Clin Exp Immunol; 2002 Dec; 130(3):415-23. PubMed ID: 12452831
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of salbutamol and salmeterol on human eosinophil responses.
Ezeamuzie CI; al-Hage M
J Pharmacol Exp Ther; 1998 Jan; 284(1):25-31. PubMed ID: 9435156
[TBL] [Abstract][Full Text] [Related]
9. Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism.
Robinson AJ; Kashanin D; O'Dowd F; Williams V; Walsh GM
J Leukoc Biol; 2008 Jun; 83(6):1522-9. PubMed ID: 18332235
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthma.
Rovati GE; Baroffio M; Citro S; Brichetto L; Ravasi S; Milanese M; Crimi E; Brusasco V
Respir Res; 2006 Jul; 7(1):103. PubMed ID: 16875498
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of short-acting beta2-agonists on human granulocyte functions.
Yasui K; Kobayashi N; Yamazaki T; Agematsu K; Matsuzaki S; Nakata S; Baba A
Int Arch Allergy Immunol; 2006; 139(1):1-8. PubMed ID: 16272820
[TBL] [Abstract][Full Text] [Related]
12. Effects of (R)- and (S)-isomers of beta-adrenergic agonists on eosinophil response to interleukin-5.
Volcheck GW; Kelkar P; Bartemes KR; Gleich GJ; Kita H
Clin Exp Allergy; 2005 Oct; 35(10):1341-6. PubMed ID: 16238794
[TBL] [Abstract][Full Text] [Related]
13. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils.
Nagata M; Saito K; Kikuchi I; Hagiwara K; Kanazawa M
Int Arch Allergy Immunol; 2005; 137 Suppl 1():2-6. PubMed ID: 15947477
[TBL] [Abstract][Full Text] [Related]
14. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW
J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055
[TBL] [Abstract][Full Text] [Related]
15. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
16. Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trial.
Ramsay CF; Sullivan P; Gizycki M; Wang D; Swern AS; Barnes NC; Reiss TF; Jeffery PK
Respir Med; 2009 Jul; 103(7):995-1003. PubMed ID: 19249198
[TBL] [Abstract][Full Text] [Related]
17. Cysteinyl leukotrienes induce human eosinophil locomotion and adhesion molecule expression via a CysLT1 receptor-mediated mechanism.
Fregonese L; Silvestri M; Sabatini F; Rossi GA
Clin Exp Allergy; 2002 May; 32(5):745-50. PubMed ID: 11994100
[TBL] [Abstract][Full Text] [Related]
18. Delayed eosinophil apoptosis in asthma.
Kankaanranta H; Lindsay MA; Giembycz MA; Zhang X; Moilanen E; Barnes PJ
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):77-83. PubMed ID: 10887309
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle.
Fogli S; Stefanelli F; Martelli A; Daniele S; Testai L; Calderone V; Trincavelli ML; Martini C; Breschi MC
Pulm Pharmacol Ther; 2013 Dec; 26(6):693-9. PubMed ID: 23810957
[TBL] [Abstract][Full Text] [Related]
20. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
